Statements (57)
Predicate | Object |
---|---|
gptkbp:instanceOf |
species
|
gptkbp:affiliatedWith |
genus_Trypanosoma
|
gptkbp:causedBy |
gptkb:African_sleeping_sickness
|
gptkbp:diseaseResistance |
serological tests
blood smear |
gptkbp:hasAppearedIn |
certain antibiotics
|
gptkbp:hasHistory |
humans
cattle wild animals |
gptkbp:hasPersonalityTrait |
amastigote
epimastigote promastigote trypomastigote |
gptkbp:hasSibling |
approximately 25 million base pairs
|
https://www.w3.org/2000/01/rdf-schema#label |
Trypanosoma brucei
|
gptkbp:isA |
protozoan parasite
|
gptkbp:isAttendedBy |
environmental factors
host immune response |
gptkbp:isCharacterizedBy |
single nucleus
flagellum kinetoplast |
gptkbp:isConsidered |
neglected tropical disease
|
gptkbp:isDividedInto |
Trypanosoma brucei gambiense
Trypanosoma_brucei_brucei Trypanosoma_brucei_rhodesiense |
gptkbp:isInvolvedIn |
public health initiatives
vector control programs epidemics_in_Africa |
gptkbp:isKnownFor |
metabolic pathways
cell signaling pathways antigenic variation |
gptkbp:isMonitoredBy |
gptkb:World_Health_Organization
|
gptkbp:isPartOf |
Euglenozoa phylum
Trypanosoma genus Trypanosomiasis Excavata_supergroup |
gptkbp:isRelatedTo |
Leishmania spp.
Trypanosoma cruzi |
gptkbp:isStudiedIn |
molecular biology
biochemistry genetics vaccine development host-parasite interactions antiparasitic drugs parasitology drug resistance mechanisms treatment strategies pathogenesis |
gptkbp:isUsedFor |
pentamidine
suramin eflornithine nifurtimox |
gptkbp:isVisitedBy |
bloodstream
central nervous system lymphatic system |
gptkbp:locatedIn |
sub-Saharan Africa
|
gptkbp:safetyFeatures |
tsetse fly
|